ArticleEpilepsia open2026

Efficacy and safety of perampanel as first adjunctive therapy in patients with focal-onset seizures or generalized tonic-clonic seizures in four post-marketing studies across regions.

Stefano Meletti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.